Prior studies suggest that elevated FDP is associated with HCC and other malignancies, serving as a diagnostic biomarker to differentiate malignant from non-malignant ascites and correlating with liver dysfunction or cirrhosis (30–32). The gene discussed is OTOR; the disease is Decreased liver function.